In contrast, anemoside B4 significantly increased Bcl-2/Bax ratio and reduced cleaved caspase3 and p53 protein levels in a dose dependent manner, suggesting that anemoside B4 could reduce colitis apoptosis in colons (Fig. 3e, f). Here, BAX is linked to colitis.